Hui Cao

机构：Shanghai Jiao Tong University, Peking University, Renji Hospital, Yale University, Ministry of Education, Mianyang Third People's Hospital, Suizhou Central Hospital, Tongren Hospital, Columbia University · ORCID：0000-0002-5901-5499

发表论文 70 篇 · 总被引 1379 次 · h-index 21

代表论文

• Genomic and transcriptomic landscape of human gastrointestinal stromal tumors (2024 · Nature Communications · 被引 27)
• Global trends in tumor microenvironment-related research on tumor vaccine: a review and bibliometric analysis (2024 · Frontiers in Immunology · 被引 11)
• Clinical Benefit of Avapritinib in KIT- Mutant Gastrointestinal Stromal Tumors: A Post Hoc Analysis of the Phase I NAVIGATOR and Phase I/II CS3007–001 Studies (2023 · Clinical Cancer Research · 被引 9)
• Trends of genetic contributions on epigenetic clocks and related methylation sites with aging: A population‐based adult twin study (2024 · Aging Cell · 被引 8)
• Phase 1 study of NB003, a broad-spectrum KIT/PDGFRα inhibitor, in patients with advanced gastrointestinal stromal tumors (GIST). (2024 · Journal of Clinical Oncology · 被引 5)
• Comprehensive analysis reveals dual biological function roles of EpCAM in kidney renal clear cell carcinoma (2023 · Heliyon · 被引 4)